Effect of curcuminoids on contrast-induced nephropathy after coronary intervention

Effect of curcuminoids on contrast-induced nephropathy after coronary intervention : Randomized, prospective, double-blind, placebo-controlled trial.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20160721001

Enrollment

Unknown

Registered

2016-07-21

Start date

2013-05-30

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient who had Coronary artery disease which undergoing PCI. Curcuminoids Contrast&#45

Interventions

Curcuminoids reduce nephropathy after coronary intervention&#44

Randomized&#44

prospective&#44

double&#45

blind&#44

placebo&#45

controlled.,Placebo comparator

Experimental Drug,Placebo Comparator No treatment

curcuminoids,Placebo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient who had Coronary artery disease which undergoing Percutaneous coronary intervention (PCI).

Exclusion criteria

Exclusion criteria: 1. Systolic Blood pressure < 90 mm.Hg. 2. Emergency PCI 3. Acute Renal Failure from other cause 4. Cholestatic jaundice 5. Received Nephrotoxic drug

Design outcomes

Primary

Measure	Time frame
contrast-induced nephropathy After PCI neutrophil gelatinase associated lipocalin (NGAL) level.	—

Secondary

Measure	Time frame
Myocardial Necrosis After Percutaneous Coronary Intervention 0, 24 and 48 hour after PCI Cardiac Biomaker	—

Countries

Thailand

Contacts

Public ContactWanwarang Wongcharoen

Faculty of Medicine, Chiang Mai University

bwanwarang@yahoo.com+66 5393 6716

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026

Effect of curcuminoids on contrast&#45;induced nephropathy after coronary intervention